Ancillary Study GOG 158: Survival Analysis Based on Reclassification to a Two-Tier Grading System

Completed

Conditions studied: Ovarian Cancer

In brief

Primary Objective: * To reclassify the histologic grade of the serous ovarian cancer specimens of patients enrolled on Gynecologic Oncology Group (GOG) protocol 158 using a two-tier system. Secondary Objective: * To determine the overall and progression-free survival of patients with serous carcinoma of the ovary treated on GOG protocol 158 when reclassified according to tumor grade (low vs. high). Tertiary Objective: * To correlate histologic grade with other prognostic factors.

Key facts

Study ID

NCT00837993

Run by

M.D. Anderson Cancer Center

People needed

241

Starts

2007-08-01

Expected to finish

2012-12-01

Last updated by the study team

2012-12-21

Who can join

Age: any. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• All patients enrolled on GOG protocol 158 with a diagnosis of serous carcinoma of the ovary.

You may not qualify if…

• None

Where it is running

• UT MD Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.